Status:
COMPLETED
The Use of Artificial Intelligence to Predict Cancerous Lymph Nodes for Lung Cancer Staging During Ultrasound Imaging
Lead Sponsor:
St. Joseph's Healthcare Hamilton
Conditions:
Lung Diseases
Lung Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to determine if a deep neural artificial intelligence (AI) network (NeuralSeg) can learn how to assign the Canada Lymph Node Score to lymph nodes examined by endobronchial ultrasound t...
Eligibility Criteria
Inclusion
- must be diagnosed with confirmed or suspected lung cancer and be undergoing EBUS diagnosis/staging
Exclusion
- None
Key Trial Info
Start Date :
April 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 20 2019
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT03849040
Start Date
April 8 2019
End Date
November 20 2019
Last Update
March 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 4A6